Rx Reimport Options Being Weighed By Jeffords After Defeat In House, HHS
Executive Summary
Sen. Jeffords (I-Vt.) is weighing options for how to address prescription drug reimportation in the Senate following rejection of reimportation by the House and HHS.
You may also be interested in...
Rx Importation Sinks In Senate, But Leaves Anticounterfeiting Regs In Its Wake
Although the drug importation provisions included in the Senate's version of the FDA Revitalization Act are not expected to create a cross-border trading system, their anticounterfeiting language could still have a significant impact on industry
Rx Importation Sinks In Senate, But Leaves Anticounterfeiting Regs In Its Wake
Although the drug importation provisions included in the Senate's version of the FDA Revitalization Act are not expected to create a cross-border trading system, their anticounterfeiting language could still have a significant impact on industry
Rx Imports: House Cmte. Tells FDA To Consider “Counterfeit-Proof” Packages
Reimportation advocates want FDA to consider "counterfeit-proof" drug packaging technologies that could enable U.S. consumers to safely import prescriptions from Canada